Press "Enter" to skip to content

New patent for Novartis drug XIIDRA

0
Copyright © DrugPatentWatch. Originally published at New patent for Novartis drug XIIDRA

Annual Drug Patent Expirations for XIIDRA
Annual Drug Patent Expirations for XIIDRA

Xiidra is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting this drug.

XIIDRA drug price trends.

Drug patent litigation for XIIDRA.

This drug has one hundred and seven patent family members in twenty-one countries.

The generic ingredient in XIIDRA is lifitegrast. Two suppliers are listed for this compound. Additional details are available on the lifitegrast profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Novartis drug XIIDRA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions